About

CorePharma is a pharmaceutical company dedicated to the contract development and manufacturing space. Founded in 1998 and headquartered in Middlesex, NJ, CorePharma has become a leading player in the CDMO space. CorePharma are experts in developing and manufacturing oral solid products on behalf of our clients. With the help of our 100,000+ square foot cGMP compliant facilities, 3 billion units a year capacity, remarkable equipment, and dedicated expertise to create high-quality products that meet regulatory requirements. CorePharma works with clients from the early stages of drug development all the way through to commercialization, providing a seamless transition from development to manufacturing. We provide a number of benefits to our clients; including access to specialized expertise, advanced technology, and state-of-the-art facilities. We support our clients throughout the development process with flexibility and scalability, allowing any of our clients to rapidly scale up or down their manufacturing operations as needed. CorePharma also places a strong emphasis on customer service, striving to build long-term partnerships with their customers by providing excellent service and support. We work closely with our customers to understand their unique needs and tailor their offerings to meet those needs. We are dedicated to improving the health and well-being of people around the world by providing safe, effective, and affordable medications to all. About CorePharma CorePharma is a "Quality Driven + People Powered" US based contract development and manufacturing organization (CDMO) of high-quality pharmaceuticals across various therapeutic categories. Our focus is on providing end-to-end solutions from early-stage drug development through commercial launch and beyond. With an excellent regulatory inspection track record, CorePharma currently operates 5 state of the art, US FDA and DEA registered, development, analytical, clinical and commercial manufacturing and packaging facilities totaling 150,000 sqft and an annual capacity to produce 4 billion dosage units per year. With industry leading lead times, we can truly accelerate your timelines to get your project from the lab to the clinic to the patient. At CorePharma, we are committed to being your concept to commercial CDMO platform for success. About CorePharma CorePharma is a "Quality Driven + People Powered" US based contract development and manufacturing organization (CDMO) of high-quality pharmaceuticals across various therapeutic categories. Our focus is on providing end-to-end solutions from early-stage drug development through commercial launch and beyond. With an excellent regulatory inspection track record, CorePharma currently operates 5 state of the art, US FDA and DEA registered, development, analytical, clinical and commercial manufacturing and packaging facilities totaling 150,000 sqft and an annual capacity to produce 4 billion dosage units per year. With industry leading lead times, we can truly accelerate your timelines to get your project from the lab to the clinic to the patient. At CorePharma, we are committed to being your concept to commercial CDMO platform for success. CorePharma is a leading U.S.-based contract development and manufacturing organization (CDMO), dedicated to delivering high-quality pharmaceuticals across diverse therapeutic categories. We provide comprehensive, end-to-end solutions—from early-stage drug development to commercial launch and beyond. With a proven track record of regulatory excellence, CorePharma operates 4 state-of-the-art, FDA- and DEA-registered facilities, spanning 150,000 square feet. Our advanced development, analytical, clinical, and commercial manufacturing and packaging capabilities support an annual production capacity of 5 billion dosage units. Backed by industry-leading lead times, we accelerate your journey from the lab to the clinic—and ultimately to the patient. At CorePharma, we are committed to being your concept to commercial CDMO platform for success.